BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer

Incyte Biosciences Japan G.K. announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination w...

December 23, 2025 | News

Japanese Skincare Brand Yii Partners With ANDS Corporation To Bring Pharmaceutical Grade Science To Sensitive Skin

Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter "ANDS"), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the nic...

December 23, 2025 | News

Alphamab Oncology’s JSKN003 Gains FDA Breakthrough Therapy Designation For Platinum Resistant Ovarian Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the...

December 23, 2025 | News

MEDI&GENE Enters Catalyze Agreement With Eli Lilly To Advance Next Generation Obesity Therapy

MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreeme...

December 19, 2025 | News

UK Hospitals Adopt AI Tool MEMORI To Strengthen Early Detection Of Hospital Acquired Infections

Sanome, the health tech company behind MEMORI, an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs...

December 18, 2025 | News

GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology di...

December 17, 2025 | News

Peijia Medical Secures China Regulatory Approval For TaurusTrio Transcatheter Aortic Valve System

Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, a...

December 16, 2025 | News

AusperBio Reports 30% Functional Cure Rate With AHB 137 In Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oli...

December 16, 2025 | Report

Telix Pharmaceuticals And Varian Enter Strategic Collaboration To Advance Precision Radiation Oncology

Telix Pharmaceuticals Limited announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncol...

December 12, 2025 | News

Rhinocare Korea Sets Up Singapore Joint Venture To Drive Global Expansion In Drug Free Respiratory Care

Rhinocare Korea, a medtech innovator specializing in drug-free respiratory care, announced plans to establish a joint venture (JV) in Singapore a...

December 12, 2025 | News

South Korea Takes A Major Step Toward Blood Based Alzheimer’s Diagnosis With Simoa Platform Approval

Quanterix Corporation (NASDAQ: QTRX), a U.S.-based biotechnology company specializing in ultrasensitive biomarker detection, and its clinical diagnostics b...

December 12, 2025 | News

How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026

Health systems have become more consolidated. Some are acting as both providers and payers, and therefore have more influence as gatekeepers of market acce...

December 10, 2025 | Report

SoluPet Partners With CHC To Launch Canine Cognitive Health Solution In Taiwan

SoluPet, the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs, today announc...

December 10, 2025 | News

PT Fapon Bioindustries Indonesia And Bio Farma Sign Strategic IVD Manufacturing Partnership

PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred...

December 09, 2025 | News

Stay Connected